Alterations in the gut microbiota can elicit hypertension in rats

Physiological Genomics

Volumn 49, Issue 2, 2017, Pages 96-104

  Adnan, Sareema ^a   Nelson, James W ^b   Ajami, Nadim J ^b   Venna, Venugopal R ^c   Petrosino, Joseph F ^b   Bryan, Robert M ^b   Durgan, David J ^b  

^a UNIVERSITY OF HOUSTON   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Dysbiosis; Hypertension; Microbiota; Short chain fatty acids; Spontaneously hypertensive rat

Indexed keywords

RNA 16S;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTEROIDETES; CECUM; CONTROLLED STUDY; DYSBIOSIS; FIRMICUTES; HYPERTENSION; INTESTINE FLORA; NONHUMAN; PLETHYSMOGRAPHY; PRIORITY JOURNAL; RAT; RNA SEQUENCE; STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; ANIMAL; BIODIVERSITY; BLOOD PRESSURE; FECES; METABOLOME; MICROBIOLOGY; PATHOPHYSIOLOGY; PHYLOGENY; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLE; WISTAR KYOTO RAT;

ANIMALS; BIODIVERSITY; BLOOD PRESSURE; FECES; GASTROINTESTINAL MICROBIOME; HYPERTENSION; METABOLOME; PHYLOGENY; RATS, INBRED SHR; RATS, INBRED WKY; SYSTOLE;

EID: 85013149221     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00081.2016     Document Type: Article

References (33)

1. Babidge W, Millard S, Roediger W. Sulfides impair short chain fatty acid beta-oxidation at acyl-CoA dehydrogenase level in colonocytes: implications for ulcerative colitis. Mol Cell Biochem 181: 117–124, 1998. doi: 10.1023/A: 1006838231432.
2. Berni Canani R, Di Costanzo M, Leone L. The epigenetic effects of butyrate: potential therapeutic implications for clinical practice. Clin Epigenetics 4: 4, 2012. doi: 10.1186/1868-7083-4-4.
3. Blumberg R, Powrie F. Microbiota, disease, and back to health: a metastable journey. Sci Transl Med 4: 137rv7, 2012. doi: 10.1126/ scitranslmed.3004184.
4. Brown JM, Hazen SL. Metaorganismal nutrient metabolism as a basis of cardiovascular disease. Curr Opin Lipidol 25: 48–53, 2014. doi: 10.1097/ MOL.0000000000000036.
5. Campbell JM, Fahey GC Jr, Wolf BW. Selected indigestible oligosaccharides affect large bowel mass, cecal and fecal short-chain fatty acids, pH and microflora in rats. J Nutr 127: 130–136, 1997.
6. Canani RB, Costanzo MD, Leone L, Pedata M, Meli R, Calignano A. Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J Gastroenterol 17: 1519–1528, 2011. doi: 10.3748/wjg. v17.i12.1519.
7. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Peña AG, Goodrich JK, Gordon JI, Huttley GA, Kelley ST, Knights D, Koenig JE, Ley RE, Lozupone CA, McDonald D, Muegge BD, Pirrung M, Reeder J, Sevinsky JR, Turn-baugh PJ, Walters WA, Widmann J, Yatsunenko T, Zaneveld J, Knight R. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7: 335–336, 2010. doi: 10.1038/nmeth.f.303.
8. Durgan DJ, Ganesh BP, Cope JL, Ajami NJ, Phillips SC, Petrosino JF, Hollister EB, Bryan RM Jr. Role of the gut microbiome in obstructive sleep apnea-induced hypertension. Hypertension 67: 469–474, 2016. doi: 10.1161/HYPERTENSIONAHA.115.06672.
9. Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26: 2460–2461, 2010. doi: 10.1093/bioinformatics/btq461.
10. Everard A, Cani PD. Diabetes, obesity and gut microbiota. Best Pract Res Clin Gastroenterol 27: 73–83, 2013. doi: 10.1016/j.bpg.2013.03.007.
11. Foster JA, McVey Neufeld KA. Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci 36: 305–312, 2013. doi: 10.1016/j.tins.2013.01.005.
12. Gómez-Guzmán M, Toral M, Romero M, Jiménez R, Galindo P, Sánchez M, Zarzuelo MJ, Olivares M, Gálvez J, Duarte J. Antihypertensive effects of probiotics Lactobacillus strains in spontaneously hypertensive rats. Mol Nutr Food Res 59: 2326–2336, 2015. doi: 10.1002/mnfr. 201500290.
13. Grassi D, Desideri G, Di Giosia P, De Feo M, Fellini E, Cheli P, Ferri L, Ferri C. Tea, flavonoids, and cardiovascular health: endothelial protection. Am J Clin Nutr 98, Suppl: 1660S–1666S, 2013. doi: 10.3945/ajcn. 113.058313.
14. Gregory JC, Buffa JA, Org E, Wang Z, Levison BS, Zhu W, Wagner MA, Bennett BJ, Li L, DiDonato JA, Lusis AJ, Hazen SL. Transmission of atherosclerosis susceptibility with gut microbial transplantation. J Biol Chem 290: 5647–5660, 2015. doi: 10.1074/jbc.M114.618249.
15. Hoban AE, Stilling RM, Ryan FJ, Shanahan F, Dinan TG, Claesson MJ, Clarke G, Cryan JF. Regulation of prefrontal cortex myelination by the microbiota. Transl Psychiatry 6: e774, 2016. doi: 10.1038/tp.2016.42.
16. Honour J. The possible involvement of intestinal bacteria in steroidal hypertension. Endocrinology 110: 285–287, 1982. doi: 10.1210/endo-110-1-285.
17. Honour JW, Borriello SP, Ganten U, Honour P. Antibiotics attenuate experimental hypertension in rats. J Endocrinol 105: 347–350, 1985. doi: 10.1677/joe.0.1050347.
18. Juraschek SP, Bower JK, Selvin E, Subash Shantha GP, Hoogeveen RC, Ballantyne CM, Young JH. Plasma lactate and incident hypertension in the atherosclerosis risk in communities study. Am J Hypertens 28: 216–224, 2015. doi: 10.1093/ajh/hpu117.
19. Kelly CJ, Zheng L, Campbell EL, Saeedi B, Scholz CC, Bayless AJ, Wilson KE, Glover LE, Kominsky DJ, Magnuson A, Weir TL, Ehrentraut SF, Pickel C, Kuhn KA, Lanis JM, Nguyen V, Taylor CT, Colgan SP. Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function. Cell Host Microbe 17: 662–671, 2015. doi: 10.1016/j.chom.2015.03.005.
20. Khalesi S, Sun J, Buys N, Jayasinghe R. Effect of probiotics on blood pressure: a systematic review and meta-analysis of randomized, controlled trials. Hypertension 64: 897–903, 2014. doi: 10.1161/HYPERTENSIONAHA.114.03469.
21. Koeth RA, Levison BS, Culley MK, Buffa JA, Wang Z, Gregory JC, Org E, Wu Y, Li L, Smith JD, Tang WH, DiDonato JA, Lusis AJ, Hazen SL. -Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO. Cell Metab 20: 799–812, 2014. doi: 10.1016/j.cmet.2014.10.006.
22. Konrad D, Wueest S. The gut-adipose-liver axis in the metabolic syndrome. Physiology (Bethesda) 29: 304–313, 2014. doi: 10.1152/physiol. 00014.2014.
23. Mell B, Jala VR, Mathew AV, Byun J, Waghulde H, Zhang Y, Haribabu B, Vijay-Kumar M, Pennathur S, Joe B. Evidence for a link between gut microbiota and hypertension in the Dahl rat. Physiol Genomics 47: 187–197, 2015. doi: 10.1152/physiolgenomics.00136.2014.
24. Miyake S, Kim S, Suda W, Oshima K, Nakamura M, Matsuoka T, Chihara N, Tomita A, Sato W, Kim SW, Morita H, Hattori M, Yamamura T. Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to Clostridia XIVa and IV clusters. PLoS One 10: e0137429, 2015. doi: 10.1371/journal.pone. 0137429.
25. Okamoto K, Aoki K. Development of a strain of spontaneously hypertensive rats. Jpn Circ J 27: 282–293, 1963. doi: 10.1253/jcj.27.282.
26. Pinto YM, Paul M, Ganten D. Lessons from rat models of hypertension: from Goldblatt to genetic engineering. Cardiovasc Res 39: 77–88, 1998. doi: 10.1016/S0008-6363 (98) 00077-7.
27. Pluznick JL, Protzko RJ, Gevorgyan H, Peterlin Z, Sipos A, Han J, Brunet I, Wan LX, Rey F, Wang T, Firestein SJ, Yanagisawa M, Gordon JI, Eichmann A, Peti-Peterdi J, Caplan MJ. Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation. Proc Natl Acad Sci USA 110: 4410–4415, 2013. doi: 10.1073/pnas.1215927110.
28. Potenza MA, Marasciulo FL, Tarquinio M, Tiravanti E, Colantuono G, Federici A, Kim JA, Quon MJ, Montagnani M. EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR. Am J Physiol Endocrinol Metab 292: E1378–E1387, 2007. doi: 10.1152/ ajpendo.00698.2006.
29. Rosenbaum M, Knight R, Leibel RL. The gut microbiota in human energy homeostasis and obesity. Trends Endocrinol Metab 26: 493–501, 2015. doi: 10.1016/j.tem.2015.07.002.
30. Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, Huttenhower C. Metagenomic biomarker discovery and explanation. Genome Biol 12: R60, 2011. doi: 10.1186/gb-2011-12-6-r60.
31. Takagaki A, Nanjo F. Effects of metabolites produced from (-)-epigallocatechin gallate by rat intestinal bacteria on angiotensin I-converting enzyme activity and blood pressure in spontaneously hypertensive rats. J Agric Food Chem 63: 8262–8266, 2015. doi: 10.1021/acs.jafc.5b03676.
32. Ussar S, Griffin NW, Bezy O, Fujisaka S, Vienberg S, Softic S, Deng L, Bry L, Gordon JI, Kahn CR. Interactions between gut microbiota, host genetics and diet modulate the predisposition to obesity and metabolic syndrome. Cell Metab 22: 516–530, 2015. doi: 10.1016/j.cmet.2015.07. 007.
33. Yang T, Santisteban MM, Rodriguez V, Li E, Ahmari N, Carvajal JM, Zadeh M, Gong M, Qi Y, Zubcevic J, Sahay B, Pepine CJ, Raizada MK, Mohamadzadeh M. Gut dysbiosis is linked to hypertension. Hypertension 65: 1331–1340, 2015. doi: 10.1161/HYPERTENSIONAHA.115.05315.